Focus Merit

Phase-I clinical Human trial of coronavirus vaccine starts in US

Phase-I clinical Human trial of coronavirus vaccine starts in US
  • The United State has begun the phase one of the clinical Human trial of an investigational vaccine designed to save against the coronavirus disease which has claimed the lives of over 7,000 people globally.
  • The trial has been begun at the Kaiser Permanente Washington Health Research Institute (KPWHRI) in Seattle.
Exit mobile version